HPS Pharmacies wish to give notice that Merck Sharp & Dohme is experiencing a supply interruption for OncoTICE® as follows:
Mycobacterium bovis (Bacillus Calmette and Guerin (BCG) strain) 5 hundred million CFU
This supply interruption is due to an unexpected increase in demand as well as COVID-related supply chain issues. Merck Sharp & Dohme anticipate that limited availability is likely to extend into late-2024. However, the current out-of-stock situation is expected to be temporary.
Retain this notice in a prominent position, including in other related business units until supplies return to normal. Report any problems identified with medicines, vaccines or medical devices to the TGA.
Should you require further information regarding this matter, please contact Merck Sharp & Dohme on 1800 818 553 or your pharmacist at HPS Pharmacies.
Subscribe Knowledge Centre Updates
Enter your details to receive Knowledge Centre updates